218 related articles for article (PubMed ID: 9758595)
21. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
[TBL] [Abstract][Full Text] [Related]
23. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
[TBL] [Abstract][Full Text] [Related]
24. [Von Hippel-Lindau disease].
Shuin T; Ashida S; Yao M; Kanno H
Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
[TBL] [Abstract][Full Text] [Related]
25. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
26. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
28. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
Decker HJ; Weidt EJ; Brieger J
Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
[TBL] [Abstract][Full Text] [Related]
29. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report.
Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB
Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic analysis and mutation screening of the VHL gene in a Japanese family with von Hippel-Lindau disease.
Wu Y; Nishio H; Lee MJ; Ayaki H; Hayashi A; Ooba T; Ogawa T; Sumino K
Kobe J Med Sci; 2000 Aug; 46(4):147-53. PubMed ID: 11354926
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
32. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
Friedrich CA
Hum Mol Genet; 2001 Apr; 10(7):763-7. PubMed ID: 11257110
[TBL] [Abstract][Full Text] [Related]
34. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
35. Pathology, genetics and cell biology of hemangioblastomas.
Wizigmann-Voos S; Plate KH
Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
[TBL] [Abstract][Full Text] [Related]
36. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
Martin R; Hockey A; Walpole I; Goldblatt J
Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
[TBL] [Abstract][Full Text] [Related]
38. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
40. Von Hippel-Lindau disease: the role of gene analysis in affected families.
Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A
Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]